These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38605773)

  • 1. Diagnosis of a recurred lesion in dermatophytosis patients after 2 weeks of antifungal therapy: A prospective observational study.
    Sirka CS; Behera B; Pradhan S; Rout AN; Sahu K; Dash G; Jena J
    J Family Med Prim Care; 2024 Feb; 13(2):465-470. PubMed ID: 38605773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinico-Mycological Profile of Treatment-Naïve, Chronic, Recurrent and Steroid-Modified Dermatophytosis at a Tertiary Care Centre in Eastern India: An Institution-Based Cross-SectionalStudy.
    Saha I; Podder I; Chowdhury SN; Bhattacharya S
    Indian Dermatol Online J; 2021; 12(5):714-721. PubMed ID: 34667758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).
    Rengasamy M; Shenoy MM; Dogra S; Asokan N; Khurana A; Poojary S; Jayaraman J; Valia AR; Sardana K; Kolalapudi S; Marfatia Y; Rao PN; Bhat RM; Kura M; Pandhi D; Barua S; Kaushal V
    Indian Dermatol Online J; 2020; 11(4):502-519. PubMed ID: 32832435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis.
    Khattab F; Elkholy BM; Taha M; Abd-Elbaset A; Fawzy M
    Mycoses; 2022 Dec; 65(12):1194-1201. PubMed ID: 35943822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of the epidemiological and clinical patterns of recurrent dermatophytosis at a tertiary care hospital in India.
    Pathania S; Rudramurthy SM; Narang T; Saikia UN; Dogra S
    Indian J Dermatol Venereol Leprol; 2018; 84(6):678-684. PubMed ID: 30058568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Clinical-Mycological Study of Dermatophytosis in Western India with Focus on Antifungal Drug Resistance as a Factor in Recalcitrance.
    Shah SR; Vyas HR; Shah BJ; Jangid NC; Choudhary A; Gehlawat T; Mistry D; Joshi R
    Indian J Dermatol; 2023; 68(2):234. PubMed ID: 37275803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse after Oral Terbinafine Therapy in Dermatophytosis: A Clinical and Mycological Study.
    Majid I; Sheikh G; Kanth F; Hakak R
    Indian J Dermatol; 2016; 61(5):529-33. PubMed ID: 27688443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of efficacy and safety of oral voriconazole in the management of recalcitrant and recurrent dermatophytosis.
    B S C; D S P
    Clin Exp Dermatol; 2022 Jan; 47(1):30-36. PubMed ID: 34115896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Clinico-mycological, Antifungal Drug Sensitivity and Therapeutic Study of Extensive Dermatophytosis in Coastal Andhra Pradesh.
    Vanapalli S; Turpati NR; Gopal KVT; Krishnam Raju PV; Devi BG
    Indian Dermatol Online J; 2022; 13(6):747-753. PubMed ID: 36386757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study.
    Tahiliani S; Saraswat A; Lahiri AK; Shah A; Hawelia D; Shah GK; Girdhar M; Rao PN; Raghav PA; Agarwal P; Kharkar RD; Gupta RP; Udare S; Hegde S; Haldar S
    Indian J Dermatol Venereol Leprol; 2021; 87(6):800-806. PubMed ID: 34160163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinea pedis: an updated review.
    Leung AK; Barankin B; Lam JM; Leong KF; Hon KL
    Drugs Context; 2023; 12():. PubMed ID: 37415917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of plasma levels of itraconazole with treatment response at 4 weeks in chronic dermatophytosis: Results of a randomised controlled trial.
    Bhalavi H; Shaw D; Mehta H; Narang T; Sachdeva N; Shafiq N; Rudramurthy SM; Dogra S
    Mycoses; 2023 Apr; 66(4):281-288. PubMed ID: 36457207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication Practice of Patients with Dermatophytosis.
    Poudyal Y; Joshi SD
    JNMA J Nepal Med Assoc; 2016; 55(203):7-10. PubMed ID: 27935915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the benefit of the addition of 1% topical luliconazole versus topical bland emollient to the systemic itraconazole therapy for the management of disseminated dermatophytosis: A randomised control trial.
    Rana DK; Shah TS; Rohit MH; Patel NH; Khadela AD; Oza YP; Padhiyar JK
    Mycoses; 2024 Jan; 67(1):e13681. PubMed ID: 38214352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Recalcitrant Dermatophytosis in a Multicenter Study in Sri Lanka.
    Madarasingha NP; Eriyagama S; Jayasekera PI; de Silva Weliange S; Gunasekera S; Munasingha DM; Rajendran P; Ekanayaka SMB; Liyanange J; Thamilvannan N; Sumanasena B; Srisaravanabavanathan F; Wijenayake B
    Am J Trop Med Hyg; 2022 Jul; 107(1):117-121. PubMed ID: 35895368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole.
    Möhrenschlager M; Schnopp C; Fesq H; Strom K; Beham A; Mempel M; Thomsen S; Brockow K; Wessner DB; Heidelberger A; Ruhdorfer S; Weigl L; Seidl HP; Ring J; Abeck D
    Br J Dermatol; 2000 Nov; 143(5):1011-5. PubMed ID: 11069511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India.
    Shenoy MM; Rengasamy M; Dogra S; Kaur T; Asokan N; Sarveswari KN; Poojary S; Arora D; Patil S; Das A; Srivastava A; Katakam BK; Mahajan V
    Mycoses; 2022 Jan; 65(1):13-23. PubMed ID: 34378240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicomycological Profile of Pediatric Dermatophytoses: An Observational Study.
    Ray A; Singh BS; Kar BR
    Indian Dermatol Online J; 2022; 13(3):361-365. PubMed ID: 36225993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Terbinafine 500 mg Once Daily in Patients with Dermatophytosis.
    Babu PR; Pravin AJS; Deshmukh G; Dhoot D; Samant A; Kotak B
    Indian J Dermatol; 2017; 62(4):395-399. PubMed ID: 28794551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.